Selenium, an essential micronutrient in man, is not transported on carrier proteins in plasma, but as selenomethionine incorporated into peptides and proteins. The best understood examples of selenoproteins are the glutathione peroxidase enzymes which are part of the antioxidant scavenging system and the enzyme 5'-deiodinase responsible for the conversion of T4 to T3.
1 Because of the anti-oxidant activities of selenium-containing compounds and their proposed role in protecting from oxidative tissue damage, there is currently a lot of interest in the detection and correction of selenium deficiency in patients.
We have noted that although the plasma selenium concentration is often very low «0·5 Jlmol/L) in newly admitted, severely ill patients.? the red cell glutathione peroxidase concentration (RBC GSHPx) is relatively normal. Others have proposed that plasma selenoproteins behave as negative acute phase reactants and are redistributed from the plasma pool into the interstitial space in a manner analogous to plasma albumin.t ' We now present a case report that further supports the concept.
CASE HISTORY
A 29-year-old Asian man (MH) first presented to our hospital in April 1992 with abdominal pain and severe bloody diarrhoea. His past medical history was unremarkable and he was not taking any medication. Initial medical treatment failed to alleviate his symptoms. He was diagnosed as suffering from ulcerative colitis. A month after admission a pan-proctocolectomy and ileal-anal anastamosis with a proximal defunctioning loop ileaostomy was performed. Histology of the surgical specimens confirmed a diagnosis of ulcerative colitis. He Correspondence: Naveed Sattar, had good functional result and remained well during regular follow up.
On his most recent admission (July 1995), he presented with small bowel obstruction which did not resolve with conservative management and laparotomy was performed to release adhesions. On the evening of operation he developed pyrexia which persisted despite broad spectrum antibiotic therapy. On investigation no source of his sepsis was found. He had a further laparotomy I week later to identify the source of his sepsis, however, this was unhelpful. During the operation, two areas of small bowel were damaged and over sewn. Following this he was fasted and total parenteral nutrition (TPN) was commenced ( Fig. 1) . His TPN regimen consisted of a standard feed with vitamin and mineral (Additrace) supplements (selenium OAJlmol (30 Jlg) per day). Postoperatively, he developed severe intra-abdominal sepsis with a large paracolic and subphrenic abscess cavity communicating with small bowel and skin. Drainage of this abscess cavity was performed 3 weeks after commencement of TPN. His management following this was conservative and TPN was continued until his general condition permitted surgical repair of his fistula about 6 months after admission, together with repair of the anterior abdominal wall. Thereafter, recovery was complicated by a brief period of nausea and vomiting leading to dehydration. Eventually oral intake was initiated and TPN was replaced by enteral feeding via a nasogastric tube. Over the following month he made good clinical progress and began to eat more freely allowing nasogastric feeding to be weaned and eventually discontinued and he was discharged home.
METHODS
Fortnightly measurements of urea and electrolytes, liver function tests, calcium and albumin and serum C-reactive protein (CRP) and an assessment of vitamin and trace element concentrations, the latter including both plasma selenium concentration and RBC GSHPx, were performed as part of clinical management. Plasma selenium was determined by electrothermal atomic absorption spectrophotometry using Pd as a matrix modifiers and serum CRP was measured immunoturbidometrically. Plasma RBC GSHPx was measured by enzymatic activity using t-butyl peroxide as substrate." The between batch CVs over the working range of the assays were 4·9% and 7·3% for plasma selenium and RBC GSHPx, respectively. For serum CRP, the between batch of coefficient of variation (CV) was 8·6% for concentrations around 27mg/L, and 4·5% for concentrations around 70 mg/L, RESULTS Figure 1 shows sequential plasma selenium RBC GSHPx and serum CRP concentrations in relation to relevant clinical features. On day 16, some 9 days after his second laparotomy and 1 week after commencement of TPN, plasma selenium concentration was 0·26 j.lmol/L and serum CRP concentration was 171 mg/L, By day 32, with clinical improvement serum CRP concentration had declined to 35 mg/L and plasma selenium concentration had risen to 0·51 j.lmol/L. 3 days after formal drainage of his paracolic abscess on day 39, serum CRP and plasma selenium concentrations were measured at 107 mg/L and 0·36 j.lmoI/L, respectively. Following this, serum CRP declined gradually, although never completely normal to a 'plateau' of around 10-20 mg/L for approximately 4-5 months and simultaneously plasma selenium concentration increased and then remained relatively constant (0-48 to 0·61 j.lmoI/L). After closure of the fistula serum CRP concentration was 112 mg/L, with a corresponding plasma selenium concentration of 0·22 j.lmo1/L. Thereafter serum CRP concentration declined towards normality and plasma selenium concentration increased. Immediately prior to discharge, plasma selenium was 0-43 j.lmoljL.
In contrast to the marked perturbations in plasma selenium concentration, plasma RBC GSHPx concentration remained relatively constant, towards the lower limit of the reference interval, throughout the entire period with no obvious relationship to serum CRP.
DISCUSSION
Our case history demonstrates a striking reciprocal relationship between plasma selenium and serum CRP concentrations. The changes in plasma selenium concentration we observed were unlikely to be due to altered selenium intake as the patient was on a constant intravenous supply of selenium (0-4Ilmol/day). 7 Though selenium losses in the urine or from gut were not measured, the temporal relationship between CRP and plasma selenium suggested that increased losses are unlikely to explain the fall in plasma selenium. Previously published studies 3 -5 . 8 support this suggestion.
Hawker et aP measured plasma selenium concentrations in 175 consecutive intensive care unit patients and urinary selenium excretion in a subgroup of 20 patients and commented that urinary excretion, which in TPN patients account for around 70% of total selenium losses," could not account for the marked reductions in plasma selenium concentrations observed. They suggested that there may be significant changes in distribution of body selenium during critical illness. In line with this, they observed significant correlations between the concentration of plasma selenium and prealbumin and albumin concentrations. Berger et al. examined selenium losses and balances in 10 patients with burns' and observed low selenium and plasma GSHPx concentration which could not be explained by measured urinary or gut losses. In a related study, because of changes in a range of trace element concentrations after multiple injury in II patients, it was concluded that perturbations in selenium and zinc concentrations were compatible with an acute phase response." Our earlier observation of a strong inverse relationship between serum CRP and plasma selenium in an un selected group of patients would also support this.?
In this patient, a relatively constant RBC GSHPx concentration, further supports the suggestion that there may be redistribution of plasma selenium containing proteins. In blood, selenium is distributed between a variety of chemical species.? Further studies on the relative changes between these species are required to elucidate the mechanisms responsible for the observed fluctuations in plasma selenium.
We suggest that when interpreting plasma selenium concentrations a marker of acute phase response such as CRP should be taken into account. In clinical practice, a low plasma selenium concentration in ill patients does not necessarily indicate selenium deficiency. In patients receiving long-term TPN, a normal and persistently low plasma selenium and red cell GSHPx are indications that additional selenium input may be required.
